GHK-Cu antioxidant approach: Upregulates endogenous antioxidant enzymes (SOD, catalase, glutathione peroxidase) rather than providing antioxidants directly
[1] [6] Severe deficiencies may include symptoms of reduced heart function, suppression of bone marrow, as well as more various severe neurological symptoms possibly including sensory loss, abnormal balance and reflexes, memory and consciousness impairment, smell and taste problems, depression, irritability, confusion, and psychosis
Selected adults may increase to 7.2 mg after at least four weeks at 2.4 mg when additional weight reduction is clinically indicated. The 0.25 mg dose is the starter rather than the maintenance target
doi: 10.1016/j.biopha.2022.113528 256 NeyL-MWipplingerMGrossmannMEngertNWegnerVDMosigAS
Pharmacological treatment of the overweight patient